Geode Capital Management LLC grew its stake in shares of Tiziana Life Sciences Ltd (NASDAQ:TLSA – Free Report) by 12.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 245,722 shares of the company’s stock after buying an additional 27,041 shares during the period. Geode Capital Management LLC owned 0.23% of Tiziana Life Sciences worth $171,000 at the end of the most recent reporting period.
Separately, Zhang Financial LLC raised its stake in Tiziana Life Sciences by 34.3% during the 4th quarter. Zhang Financial LLC now owns 93,187 shares of the company’s stock worth $65,000 after acquiring an additional 23,800 shares during the period.
Tiziana Life Sciences Trading Down 0.8 %
TLSA opened at $1.28 on Friday. The company has a 50 day simple moving average of $1.18 and a two-hundred day simple moving average of $0.96. Tiziana Life Sciences Ltd has a 1-year low of $0.54 and a 1-year high of $1.91.
Tiziana Life Sciences Company Profile
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.
Further Reading
- Five stocks we like better than Tiziana Life Sciences
- What is a Dividend King?
- Magnificent 7 Stocks Send a Dire Warning to Markets
- Best Stocks Under $10.00
- Why Spotify Stock Still Has Room to Run in 2025
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Buy the Dip: Top Tech Stocks Analysts Say Are Undervalued
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.